BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31820128)

  • 1. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea.
    Song YK; Oh JM
    Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.
    van Leeuwen RW; Brundel DH; Neef C; van Gelder T; Mathijssen RH; Burger DM; Jansman FG
    Br J Cancer; 2013 Mar; 108(5):1071-8. PubMed ID: 23412102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
    Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
    BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
    Kim SH; Suh Y; Ah YM; Jun K; Lee JY
    Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation.
    Trevisan DD; Silva JB; Oliveira HC; Secoli SR; Lima MH
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):393-400. PubMed ID: 25542268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding concomitant prescription of drugs with a potential for interaction: mission impossible?
    Erdeljic V; Francetic I; Vlahovic-Palcevski V; Radosevic N; Makar-Ausperger K; Likic R
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):821-9. PubMed ID: 21084038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins.
    Egger SS; Rätz Bravo AE; Hess L; Schlienger RG; Krähenbühl S
    Drugs Aging; 2007; 24(5):429-40. PubMed ID: 17503898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East.
    Gholaminezhad S; Hadjibabaie M; Gholami K; Javadi MR; Radfar M; Karimzadeh I; Ghavamzadeh A
    Ann Hematol; 2014 Nov; 93(11):1913-22. PubMed ID: 24906215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential drug-drug interactions in outpatients with depression of a psychiatry department.
    Chen Y; Ding L
    Saudi Pharm J; 2023 Feb; 31(2):207-213. PubMed ID: 36942274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for potential drug-drug interactions in patients with chronic obstructive pulmonary disease.
    Stojadinovic D; Zivkovic Zaric R; Jankovic S; Lazic Z; Cekerevac I; Susa R
    Ir J Med Sci; 2020 Aug; 189(3):1123-1125. PubMed ID: 31807978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of potential drug-drug interactions in medical intensive care unit patients.
    Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
    Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Selected Potential Drug-Drug Interactions of Analgesic Drugs and Possible Methods of Preventing Them: Lessons Learned From the Analysis of the Real-World National Database of 38 Million Citizens of Poland.
    Kardas P; Urbański F; Lichwierowicz A; Chudzyńska E; Czech M; Makowska K; Kardas G
    Front Pharmacol; 2020; 11():607852. PubMed ID: 33536918
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021.
    Bačar Bole C; Nagode K; Pišlar M; Mrhar A; Grabnar I; Vovk T
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837485
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
    Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
    BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
    Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
    Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.